top of page
Pink Sugar

Publication

NEW 👉

Submitted paper

Original & Review paper

Case Report & Book

*Corresponding author 

IF: Impact Factor, Citation index: CI

Up date 2024.12.3

My Thesis (私の学位論文)

徳島大学附属図書館蔵本分館日誌に掲載された学位論文に関する紹介です（工藤保誠）

http://www.lib.tokushima-u.ac.jp/support/my_thesis/pdf/my_thesis_dent_kudoh-20160531.pdf

 

我が国における歯科医学の現状と 国際比較 2013 - 日本学術会議

「がん」に関するパートを工藤保誠が分担で執筆しました

http://www.scj.go.jp/ja/info/kohyo/pdf/kohyo-22-h130902.pdf

Submitted

​paper

  1. Lauriola A, Steinberg JHE, Sarubo M, Maspero E, Rossi FA, Mouri Y, Pedretti M, Hajisadeghian M, Vettori A, Vitulo N, Assfalg M, D’Onofrio M, Rossi M, Yasue A, Astegno A, Polo S, Santi S, Kudo Y*, Guardavaccaro D*. RNF32 controls the IKK complex and NF-κB signaling in intestinal stem cells. Mol Cell (in revision). (IF:14.5).

  2. Tsunematsu T, Mouri Y, Shao W, Arakaki R, Jan R, Murano K, Ishimaru N, Guardavaccaro D, Pagano M, Kudo Y*. Sustained chromosomal passenger complex activity regulates pluripotency of human embryonic carcinoma cells. Sci Signal (in revision). (IF:6.7).

Original
&
​Review
​paper
(IF 2021)
​*Corresponding author

2024

  1. Kurio N, Kamada K, Kudou K, Tsunematsu T, Kudo Y. Intraoral myeloid sarcoma in a patient with myelodysplastic syndromes: case a report. J Oral Health Biosci (in press).(IF:0).

  2. Hashimoto N, Ito S, Harazono A, Tsuchida A, Mouri Y, Yamamoto A, Ohmi Y, Furukawa K, Kudo Y, Kawasaki N, Furukawa K. Bidirectional signals generated by Siglec-7 and sialyltransferases confer the efficient escape of cancer cells from immune surveillance. iScience (in press).(IF:4.6).

  3. Kamada K, Kurio N, Mouri Y, Kudo Y. Combination treatment with hyaluronic acid synthesis and Bcl-2 inhibitors induces senolytic elimination of oral squamous cell carcinoma cells in vitro. J Oral Maxillofac Sur Med Pathol. (in press).(IF:0.4).

  4. Yoshida K, Yoshida K, Mouri Y, Takai A, Seyama M, Mekata M, Mizusawa N, Miyoshi K, Kudo Y, Ozaki K. Exploring selective sorting mechanisms of miRNAs in extracellular vesicles during Porphyromonas gingivalis infection. J Oral Biosci 66(2):365-372, 2024. doi: 10.1016/j.job.2024.04.001. (IF:2.6).

  5. Sarubo M, Mouri Y, Moromizato A, Yamada A, Jin S, Shao W, Hagita H, Miyoshi K, Kudo Y*. Involvement of TGFBI-TAGLN axis in cancer stem cell property of head and neck squamous cell carcinoma. Sci Rep 14: article number 6767, 2024. (IF:3.8).

  6. Hirata R, Iwata T, Fujita T, Nagahara T, Matsuda S, Sasaki S, Taniguchi Y, Hamamoto Y, Ouhara K, Kudo Y, Kurihara H, Mizuno N. Periostin regulates integrin expression on gingival epithelial cells. J Oral Biosci 2023 Dec 2:S1349-0079(23)00190-1. doi: 10.1016/j.job.2023.11.009. Online ahead of print. (IF:2.6).

​

2023​

  1. Jin S, Tsunematsu T, Horiguchi T, Mouri Y, Shao W, Miyoshi K, Hagita H, Sarubo M, Fujiwara N, Qi G, Ishimaru N, Kudo Y. OTUB1-YAP1 axis promotes proliferation and invasion in head and neck squamous cell carcinoma. Cancer Med 12(24):22156-22169, 2023. (IF:2.9)

  2. Shao W, Ichimura-Shinmizu M, Ogawa H, Jin S, Sutoh M, Nakamura S, Onodera M, Tawara H, Toyohara S, Hokao R, Kudo Y, Oya T, Tsuneyama K. Establishment of repeated liver biopsy technique in experimental mice. Heliyon 9(6):e16978, 2023. (IF:3.4)

  3. Kano F, Hashimoto N, Liu Y, Xia L, Nishihara T, Oki W, Kawarabayashi K, Mizusawa N, Aota K, Sakai T, Azuma M, Hibi H, Iwasaki T, Iwamoto T, Horimai N, Yamamoto A. Therapeutic benefits of factors derived from stem cells from human exfoliated deciduous teeth for radiation-induced mouse xerostomia. Sci Rep 13(1):2706-2719,2023. (IF:3.8).

  4. Ruspita I, Das P, Miyoshi K, Noma T, Snead ML, Bei M. Enam expression is regulated by Msx2. Dev Dyn 252(10):1292-1302, 2023. (IF:2)

  5. Narwidinaa A, Miyazaki A, Iwata K, Kurogoushi R, Sugimoto A, Kudo Y, Kawarabayashi K, Yamakawa Y, Akazawa Y, Kitamura T, Nakagawa H, Yamaguchi-Ueda K, Hasegawa T, Yoshizaki K, Fukumoto S, Yamamoto A, Ishimaru N, Iwasaki T, Iwamoto T. Iroquois homeobox 3 regulates odontoblast proliferation and differentiation mediated by Wnt5a expression. Biochem Biophys Res Commun 650: 47-54, 2023. (IF:2.5)

  6. Shao W, Tsunematsu T*, Umeda M, Tawara H, Fujiwara N, Mouri Y, Arakaki R, Ishimaru N, Kudo Y*. Cancer cell-derived novel periostin promotes invasion in head and neck squamous cell carcinoma. Cancer Med 12(7):8510-8525, 2023. (IF:2.9)

  7. Yoshida K, Yoshida K, Seyama M, Hiroshima Y, Mekata M, Fujiwara N, Kudo Y, Ozaki K. Porphyromonas gingivalis outer membrane vesicles in cerebral ventricles activate microglia in mice. Oral Dis 29(8):3688-3697, 2023. doi: 10.1111/odi.14413. (IF:2.9)

​

2022

  1. Jin S, Kudo Y, Horiguchi T*. The Role of Deubiquitinating Enzyme in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 24(1), 552, 2022. (IF:4.9)

  2. Horiguchi T, Tanimura A*, Miyoshi K, Hagita H, Noma T. The effect of heterozygous mutation of adenylate kinase 2 gene on neutrophil differentiation. Int J Mol Sci 23(24):16089, 2022.(IF:4.9)

  3. Shao W, Ichimura-Shimizu M, Ogawa H, Jin S, Sutoh M, Toyohara S, Hokao R,  Kudo Y, Tsuneyama K. Spontaneous Occurrence of Various Types of Hepatocellular Adenoma in the Livers of Metabolic Syndrome-Associated Steatohepatitis Model TSOD Mice. Int J Mol Sci 23(19):11923, 2022. (IF:4.9)

  4. Yamamura Y*, Miyoshi K, Mouri Y, Kudo Y, Miyamoto Y. miR155-5p can be involved in acquisition of osseointegration on titanium surface. In Vitro Cell Dev Biol 58(8):693-701, 2022. (IF:1.5).

  5. Yuwanati M, Ramadoss R, Kudo Y, Ramani P, Murugan MS. Prevalence of oral submucous fibrosis among areca nut chewers: A systematic review and meta-analysis.  Oral Dis 2022 May 3. doi: 10.1111/odi.14235. Online ahead of print. (IF:2.9)

  6. Muzio LL, Mascitti M, La Noce M, Posa F, Kudo Y, Cirillo N. Molecules and Biomaterial Technologies Affecting Stem Cell Differentiation. Stem Cells Int 2022:9783430, 2022. doi: 10.1155/2022/9783430. eCollection 2022. (IF:3.8).

  7. Miyoshi K, Hagita H, Horiguchi T, Tanimura A, Noma T. Redefining GBA gene structure unveiled the ability of Cap-independent, IRES-dependent gene regulation. Commun Biol 5(1):639, 2022. (IF:5.2).

  8. Kudoh T, Haga A, Kudoh K, Takahashi A, Sasaki M, Kudo Y, Ikushima H, Miyamoto Y. Radiomics analysis of [18F]-fluoro-2-deoxyglucose positron emission tomography for prediction of cervical lymph node metastasis in tongue squamous cell carcinoma. Oral Radiol 2022 Mar 7. doi: 10.1007/s11282-022-00600-7. Online aheNad of print. (IF:1.6).

  9. Kisoda S, Mouri Y, Kitamura N, Yamamoto T, Miyoshi K, Kudo Y*. The role of partial-EMT in the progression of head and neck squamous cell carcinoma. J Oral Biosci 64(2):176-182, 2022. (IF:2.6).

  10. Shikama Y, Kurosawa M, Furukawa M, Kudo Y, Ishimaru N, Matsushita K. Potential antiviral activity of interleukin-29 in the oral mucosa. Inflammation 45(3):1348-1361, 2022. doi: 10.1007/s10753-022-01624-1. (IF:4.5).

  11. Mizusawa N, Harada N, Iwata T, Ohigashi I, Itakura M, Yoshimoto K. Identification of protease serine S1 family member 53 as a mitochondrial protein in murine islet beta cells. Islets 14(1):1-13, 2022. (IF:1.9).

  12. Kudo Y*. Tumorigenesis and development of oral cancer: Molecular mechanism on proliferation and invasion. J Oral Health Biosci 34(2):26-33, 2022. (IF:0).

  13. Iwata K, Kawarabayashi K, Yoshizaki K, Tian T, Saito K, Sugimoto A, Kurogoushi R, Yamada A, Yamamoto A, Kudo Y, Ishimaru N, Fukumoto S, Iwamoto T. von Willebrand factor D and EGF domains, a novel extracellular matrix protein, regulates ameloblast differentiation and enamel formation. J Cell Physiol 237(3):1964-1979, 2022. (IF:4.5).

 

2021​​​

  1. Tadokoro S, Tokuyama-Toda R, Tatehara S, Ide S, Umeki H, Miyoshi K, Noma T, Satomura K. A New Induction Method for the Controlled Differentiation of Human-Induced Pluripotent Stem Cells Using Frozen Sections. Cells 10(11):2827,2021.(IF:5.1).

  2. Takaishi K, Kudo Y, Kawahito S, Kitahara H. Clinically relevant concentration of propofol and benzodiazepines did not affect in vitro angiogenesis. J Anesth 35(6):870-878, 2021. (IF:2.8).

  3. Shao W, Fujiwara N, Mouri Y, Kisoda S, Yoshida K, Yoshida K, Yumoto H, Ozaki K, Ishimaru N, Kudo Y*. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells. Sci Rep 11(1):14943, 2021. (IF:3.8).

  4. Ohe G*, Kudo Y, Kamada K, Mouri Y, Takamaru N, Kudoh K, Kurio N, Miyamoto Y. Soluble Factor from Oral Cancer Cell Lines Inhibits Interferon-γ Production by OK-432 via CD40/CD40Ligand Pathway​. Cancers 13(13):3301, 2021. (IF:4.5)

  5. Chen S, Tamaki N*, Kudo Y, Tsunematsu T, Miki K, Ishimaru N, Ito HO. Protective Effects of Resveratrol against 5-Fluorouracil-Induced Oxidative Stress and Inflammatory Responses in Human Keratinocytes. J Clin Biochem Nutr 69(3):238-246, 2021. (IF:2)

  6. Yamamura Y*, Kudo Y, Kudo K, Miyamoto Y. Actinomycotic osteomyelitis of the mandible with bone destruction: Two case reports with a review of the Japanese literatures. Oral Sci Int 18, 147-153, 2021. (IF:0.6)

 

2020​​

  1. Kitamura N*, Sento S, Yoshizawa Y, Sasabe E, Kudo Y, Yamamoto T. Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma. Int J Mol Sci 22, 240, 2020. https://doi.org/10.3390/ijms22010240. (IF:4.9)

  2. Ruspita I, Das P, Xia Y, Kelangi S, Miyoshi K, Noma T, Snead ML, D’Souza RN, Bei M. An Msx2-Sp6-Follistatin Pathway Operates During Late Stages of Tooth Development to Control Amelogenesis. Front Physiol 11, 582610, 2020. (IF:3.2)

  3. Kawakita N, Toba H, Miyoshi K, Sakamoto S, Matsumoto D, Takashima M, Aoyama M, Inoue S, Morimoto M, Nishino T, Takizawa H, Tangoku A. Bronchioalveolar stem cells derived from mouse-induced pluripotent stem cells promote airway epithelium regeneration. Stem Cell Res Ther 11(1):430, 2020. (IF:7.1)

  4. Fujiwara N, Kitamura N, Yoshida K, Yamamoto T, Ozaki K, Kudo Y*. Fusobacterium species Associated with Oral Cancer Progression. Int J Mol Sci 21(17):6207, 2020. (IF:4.9)

  5. Tsunematsu T, Arakaki R, Kawai H, Ruppert J, Yamada A, Tsuneyama K, Ishimaru N, Earnshaw WC, Pagano M, Kudo Y*. APC/C-Cdh1 is required for the termination of CPC activity upon mitotic exit. J Cell Sci 133(18):jcs251314, 2020.(IF:3.3)

  6. Tada H, Shao W, Ishimaru N, Kudo Y*. The life in Japan at the times of COVID-19. Oral Dis 2020 May 31:10.1111/odi.13449. doi: 10.1111/odi.13449. Online ahead of print. (IF: 2.9)

  7. Fujiwara N, Murakami K, Yoshida K, Sakuraie S, Kudo Y, Ozaki K, Hirota K, Fujii H, Suzuki M, Miyake Y, Yumoto H. Suppressive effects of 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymer on the adherence of Candida species and MRSA to acrylic denture resin. Heliyon 6: e04211, 2020.(IF:3.4)

  8. Kisoda S, Shao W, Fujiwara N, Mouri Y, Tsunematsu T, Jin S, Arakaki R, Ishimaru N, Kudo Y*. Prognostic value of partial-EMT-related genes in head and neck squamous cell carcinoma by a bioinformatic analysis. Oral Dis 26: 1149-1156, 2020. (IF:2.9)

  9. Horiguchi T, Miyatake Y, Miyoshi K, Tanimura A, Hagita H, Sakaue H, Noma T. Gene-expression profile reveals the genetic and acquired phenotypes of hyperactive mutant SPORTS rat. J Med Invest 67(1.2):51-61, 2020.  (IF:-)

​口腔生命科学分野発足以前の業績

2019

  1. Fujiwara N, Yumoto H, Miyamoto K, Hirota K, Nakae H, Tanaka S, Murakami K, Kudo Y, Ozaki K, Miyake Y. 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymer suppresses an increase of oral bacteria: a single-blind, cross-over clinical trials. Clin Oral Invest 23(2):739-746, 2019. (IF:3.1)

  2. Liu T, Liu J, Chen Q, Jin S, Mi S, Shao W, Kudo Y, Zeng S, Qi G. Expression of USP22 and the chromosomal passenger complex is an indicator of malignant progression in oral squamous cell carcinoma. Oncol Lett 17(2):2040-2046, 2019. (IF:2.5)

  3. Kudo Y*. Predicting cancer outcome: Artificial intelligence vs. pathologists. Oral Dis 25(3):643-645, 2019. (IF:2.9)

  4. Arakaki R, Ushio A, Kisoda S, Sato M, Nakamura Y, Yuyama K, Tateyama R, Morishita S, Monoi N, Kudo Y, Ishimaru N. Novel effects of rooibos extract on tear and saliva secretion mediated by the muscarinic acetylcholine receptor 3 in mice. J Oral Biosci 61(3):179-182, 2019. (IF:2.6)

  5. Otsuka K, Yamada A, Saito M, Ushio A, Tsunematsu T, Kudo Y, Arakaki R, Ishimaru N. Achaete-Scute Homologue 2-Regulated Follicular Helper T Cells Promote Autoimmunity in a Murine Model for Sjögren Syndrome. Am J Pathol 189(12):2414-2427, 2019. (IF:4.7)

​

2018

  1. Utaijaratrasmi P, Vaeteewoottacharn K, Tsunematsu T, Jamjantra P, Wongkham S, Pairojkul C, Khuntikeo N, Ishimaru N, Thuwajit P, Thuwajit C, Kudo Y*. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.​ Mol Cancer 17(1):10, 2018. (IF:27.7)

  2. Otsuka K, Yamada K, Taquahashi Y, Arakaki R, Ushio A, Saito M, Yamada A, Tsunematsu T, Kudo Y, Kanno J, Ishimaru N. Long-term polarization of alveolar macrophages to a profibrotic phenotype after inhalation exposure to multi-wall carbon nanotubes. PLoS One 13(10):e0205702, 2018. (IF:2.9)

  3. Ushio A, Arakaki R, Otsuka K, Yamada A, Tsunematsu T, Kudo Y, Aota K, Azuma M, Ishimaru N. CCL22-producing Resident Macrophages Enhance Autoreactive T Cell Response in Sjogren’s Syndrome. Front Immunol 9:2594, 2018. (IF:5.7)

  4. Qi G, Liu J, Mi S, Tsunematsu T, Jin S, Shao W, Liu T, Ishimaru N, Tang B, Kudo Y*. Aurora Kinase Inhibitors in Head and Neck Cancer. Curr Top Med Chem 18(3):199-213, 2018. (IF:3.4)

  5. Siriwardena SBSM, Tsunematsu T, Qi G, Ishimaru N, Kudo Y*. Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma-A Review. Int J Mol Sci 19(5) pii: E1462, 2018. (IF:4.9)

  6. Saito M, Otsuka K, Ushio A, Yamada A, Arakaki R, Kudo Y, Ishimaru N. Unique Phenotypes and Functions of Follicular Helper T Cells and Regulatory T Cells in Sjögren’s Syndrome. Curr Rheumatol Rev 14(3):239-245, 2018. (IF:1.2)

​

2017

  1. Ando T, Kudo Y**, Iizuka S, Tsunematsu T, Umehara H, Shrestha M, Matsuo T, Kubo T, Shimose S, Arihiro K, Ogawa I, Ochi M. Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma. Sci Rep 7:40187, 2017. **Co-First author. (IF:3.8).

  2. Donato V, Bonora M, Simoneschi D, Sartini D, Kudo Y, Saraf A, Florens L, Washburn MP, Stadtfeld M, Pinton P, Pagano M. The TDH-GCN5L1-Fbxo15-KBP axis limits mitochondrial biogenesis in mouse embryonic stem cells. Nat Cell Biol 19(4):341-351, 2017. (IF:17.3).

  3. Kujiraoka S, Tsunematsu T, Sato Y, Yoshida M, Ishikawa A, Tohyama R, Tanaka M, Kobayashi Y, Kondo T, Ushio A, Otsuka K, Kurosawa M, Saito M, Yamada A, Arakaki R, Nagai H, Nikai H, Takeuchi K, Nagao T, Miyamoto Y, Ishimaru N, Kudo Y*. Establishment and characterization of a clear cell odontogenic carcinoma cell line with EWSR1-ATF1 fusion gene. Oral Oncol 69:46-55, 2017. (IF:4).

  4. Ushio A, Arakaki R, Eguchi H, Hotta F, Yamada A, Kudo Y, Ishimaru N. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren’s syndrome. Int J Mol Sci 18(6) pii:E1209, 2017. (IF:4.9).

  5. Kurosawa M, Arakaki R, Yamada A, Tsunematsu T, Kudo Y, Sprent J, Ishimaru N. NF-κB2 Controls the Migratory Activity of Memory T Cells by Regulating Expression of CXCR4 in a Mouse Model of Sjögren’s Syndrome. Arthritis Rheumatol 69(11):2193-2202, 2017. (IF:11.4).

  6. Fujita Y, Masuda K, Hamada J, Shoda K, Naruto T, Hamada S, Miyakami Y, Kohmoto T, Watanabe M, Takahashi R, Tange S, Saito M, Kudo Y, Fujiwara H, Ichikawa D, Tangoku A, Otsuji E, Imoto I. KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression. Oncotarget 8(60):101130-101145, 2017. (IF:-).

  7. Tada H, Fujiwara N, Tsunematsu T, Tada Y, Arakaki R, Tamaki N, Ishimaru N, Kudo Y*. Preventive effects of mouthguard use while sleeping on recurrent aphthous stomatitis: Preliminary interventional study. Clin Exp Dent Res 3(5):198-203, 2017. (IF: 1.7).

  8. Shikama Y, Kudo Y, Ishimaru N, Funaki M. Potential Role of Free Fatty Acids in the Pathogenesis of Periodontitis and PrimarySjögren’s Syndrome. Int J Mol Sci 18(4) pii:E836, 2017. (IF: 4.9)

  9. Yamada A, Arakaki R, Saito M, Kudo Y, Ishimaru N. Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance. Front Immunol 8:403, 2017. (IF:5.7)

  10. Ushio A, Arakaki R, Yamada A, Saito M, Tsunematsu T, Kudo Y, Ishimaru N. Crucial roles of macrophages in the pathogenesis of autoimmune disease. World J Immunol 7(1):1-8, 2017. (IF: -)

  11. 工藤保誠*．口腔癌の浸潤・転移における分子メカニズム. 日本口腔外科学会雑誌 63(2):62-68, 2017.

  12. 工藤保誠*．ユビキチン分解による細胞周期制御とその破綻がもたらす癌化. J Oral Health BioSci 30(1):33-39, 2017.

​

2016

  1. Kondo T, Tsunematsu T, Yamada A, Arakaki R, Saito M, Oysuka K, Kujiraoka S, Ushio A, Kurosawa M, Kudo Y, Ishimaru N. Acceleration of tumor growth due to dysfunction in M1 macrophages and enhanced angiogenesis in an animal model of autoimmune disease. Lab Invest 96(4):468-480, 2016. (IF:5.1).

  2. Obayashi M, Yoshida M, Tsunematsu T, Ogawa I, Sasahira T, Kuniyasu H, Imoto I, Abiko Y, Xu D, Fukunaga S, Tahara H, Kudo Y, Nagao T, Takata T. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer. Oncotarget 7(7):8223-8239, 2016. (IF:-).

  3. Sugawara C, Takahashi A, Kawano F, Kudo Y, Ishimaru N, Miyamoto Y. Intraoral ultrasonography of tongue mass lesions. Dentomaxillofac Radiol 45(5):20150362, 2016. (IF:2.9).

  4. Qi G, Kudo Y**, Tang B, Liu T, Jin S, Liu J, Zuo X, Mi S, Shao W, Ma X, Tsunematsu T, Ishimaru N, Zeng S, Tatsuka M, Shimamoto F. PARP6 act as a tumor suppressor via downregulating Survivin expression in colorectal cancer. Oncotarget 7(14):18812-18824, 2016. **Co-First author. (IF:-).

  5. Hamada J, Shoda K, Masuda K, Naruto T, Fujita Y, Kohmoto T, Miyakami Y, Watanabe M, Kudo Y, Fujiwara H, Ichikawa D, Otsuji E, Imoto I. Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma. Oncotarget 7(13):17111-17128, 2016. (IF:-).

  6. Tsunematsu T, Fujiwara N, Yoshida M, Takayama Y, Kujiraoka S, Qi G, Kitagawa M, Kondo T, Yamada A, Arakaki R, Miyauchi M, Ogawa I, Abiko Y, Nikawa H, Murakami S, Takata T, Ishimaru N, Kudo Y*. Human odontogenic epithelial cells derived from epithelial rests of Malassez possesses stem cell properties. Lab Invest 96(10):1063-1075, 2016. (IF:5.1).

  7. Izawa T, Arakaki R, Mori H, Tsunematsu T, Kudo Y, Tanaka E, Ishimaru N. The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis. J Immunol 197(12):4639-4650, 2016. (IF:3.6).

  8. Saito M, Arakaki R, Yamada A, Tsunematsu T, Kudo Y, Ishimaru N. Molecular Mechanism of Nickel Allergy. Int J Mol Sci 17(2) pii:E202, 2016. (IF:4.9)

  9. Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 22(7):2195-2205, 2016. (IF:4.3)

  10. Kudo Y*, Tada H, Fujiwara N, Tada Y, Tsunematsu T, Miyake Y, Ishimaru N. Oral environment and cancer. Genes Environ 38:13, 2016. (IF:2.7)

​

2015

  1. Iwasa A, Arakaki R, Honma N, Yamada A, Kondo T, Kurosawa M, Tsunematsu T, Kudo Y, Tanaka E, Yoshimura N, Harada N, Hayashi Y, Ishimaru N. Aromatase controls Sjögren syndrome-like lesions through monocyte chemotactic protein-1 in target organ and adipose tissue-associated macrophages. Am J Pathol 185(1):151-161, 2015. (IF:4.7).

  2. Shikama Y, Kudo Y, Ishimaru N, Funaki M. Possible Involvement of Palmitate in Pathogenesis of Periodontitis. J Cell Physiol 230(12):2981-2989, 2015. (IF:4.5).

  3. Yamada A, Ushio A, Arakaki R, Tsunematsu T, Kudo Y, Hayashi Y, Ishimaru N. Impaired expansion of regulatory T cells in a neonatal thymectomy-induced autoimmune mouse model. Am J Pathol 185(11):2886-2897, 2015. (IF:4.7).

  4. Tsunematsu T, Arakaki R, Yamada A, Ishimaru N, Kudo Y*. The Non-Canonical Role of Aurora-A in DNA Replication. Front Oncol 5:187, 2015. (IF:3.5)

​

2014

  1. Ashrin MN, Arakaki R, Yamada A, Kondo T, Kurosawa M, Kudo Y, Watanabe M, Ichikawa T, Hayashi Y, Ishimaru N. A critical role for thymic stromal lymphopoietin in nickel-induced allergy in mice. J Immunol 192(9):4025-4031, 2014. (IF:3.6).

  2. Arakaki R, Eguchi H, Yamada A, Kudo Y, Iwasa A, Enkhmaa T, Hotta F, Mitamura-Aizawa S, Mitamura Y, Hayashi Y, Ishimaru N. Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren’s syndrome.
PLoS ONE 9(5):e98390, 2014. (IF:2.9).

  3. Conway SJ, Izuhara K, Kudo Y**, Litvin J, Markwald R, Ouyang G, Arron JR, Holweg CTJ, Kudo A. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci 71(7):1279-1288, 2014. **All authors contributed equally. (IF:6.2)

  4. Iizuka S, Ishimaru N, Kudo Y*. Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression.
 Cancers 6(1):396-415, 2014. (IF:4.5)

  5. Arakaki R, Yamada A, Kudo Y, Hayashi Y, Ishimaru N. Mechanism of activation-induced cell death of T cells and regulation of FasL expression. Crit Rev Immunol 34(4):301-314, 2014. (IF:0.8)

 

2013

  1. Shikama Y, Ishimaru N, Kudo Y, Bando Y, Aki N, Hayashi Y, Funaki M. Effects of free fatty acids on human salivary gland epithelial cells. J Dent Res 92:540-546, 2013. (IF:5.7).

  2. Oura R, Arakaki R, Yamada A, Kudo Y, Tanaka E, Hayashi Y, Ishimaru N. Induction of rapid T cell death and phagocytic activity by Fas-deficient lpr macrophages. J Immunol 190(2):578-585, 2013. (IF:3.6).

  3. Hatano H, Ogawa I, Shigeishi H, Kudo Y, Ohta K, Higashikawa K, Takechi M, Takata T, Kamata N. Expression of receptor for hyaluronan-mediated motility (RHAMM) in ossifying fibromas. Histol Histopathol 28(4):473-480, 2013. (IF:2.5).

  4. Nguyen PT, Tsunematsu T, Yanagisawa S, Kudo Y, Miyauchi M, Kamata N, Takata T. The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1. Br J Cancer 109(8):2248-2258, 2013. (IF:6.4)

  5. Shimizu N, Nakajima NI, Tsunematsu T, Ogawa I, Kawai H, Hirayama R, Fujimori A, Okayasu R, Ishimaru N, Takata T, Kudo Y*. Selective enhancing effect of early mitotic inhibitor 1 (Emi1) depletion on the sensitivity of doxorubicin or X-ray treatment in human cancer cells. J Biol Chem 288(24):17238-17252, 2013. (IF:4).

  6. Tsunematsu T, Takihara Y, Ishimaru N, Pagano M, Takata T, Kudo Y*. Aurora-A controls pre-replicative complex assembly and DNA replication by stabilizing geminin in mitosis. Nat Commun 4:1885, 2013. (IF:14.7). Nature Communication誌のおすすめのコンテンツで紹介されました https://www.natureasia.com/ja-jp/ncomms/abstracts/45441

  7. Yamada A, Arakaki R, Kudo Y, Ishimaru N. Targeting IL-1 in Sjögren’s syndrome. Expert Opin Ther Targets 17(4):393-401, 2013. (IF:4.6)

​

2012

  1. DesRochers TM, Shamis Y, Alt-Holland A, Kudo Y, Takata T, Wang G, Jackson-Grusby L, Garlick JA. The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma. Epigenetics 7(1):34-46, 2012. (IF:2.9).

  2. Hatano H, Shigeishi H, Kudo Y, Higashikawa K, Tobiume K, Takata T, Kamata N. Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2. J Bone Miner Metab 30(3):293-303, 2012. (IF:2.4).

  3. Inubushi T, Kawazoe A, Miyauchi M, Kudo Y, Ao M, Ishikado A, Makino T, Takata T. Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem 287(28):23527-23536, 2012.(IF:4).

  4. Bucchieri F, Fucarino A, Gammazza AM, Pitruzzella A, Marciano` V, Paderni C, De Caro V, Siragusa MG, Lo Muzio L, Holgate ST, Davies DE, Farina F, Zummo G, Kudo Y, Giannola IL, Campisi G. Medium-term culture of normal human oral mucosa: a novel three-dimensional model to study the effectiveness of drugs administration. Curr Pharm Des 18(34):5421-5430, 2012.(IF:2.6).

  5. D'Angiolella V, Donate V, Forrester FM, Jeong YT, Pellacani C, Kudo Y, Saraf A, Florens L, Washburn MP, Pagano M. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell 149(5):1023-1034, 2012. (IF45.5).

  6. Kudo Y*, Iizuka S, Yoshida M, Nguyen PT, Siriwardena SBSM, Tsunematsu T, Obayashi M, Ando T, Hatakeyama D, Shibata T, Koizumi K, Maeda M, Ogawa I, Takata T. Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer. PLoS ONE 7(8):e44488, 2012. (IF:2.9).

  7. Kudo Y*, Iizuka S, Yoshida M, Tsunematsu T, Subarnbhesaj A, Siriwardena SB, Tahara H, Ogawa I, Takata T. Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis. J Biol Chem 287(46):38716-38728, 2012. (IF:4).

  8. Hatano H, Kudo Y, Ogawa I, Shimasue H, Shigeishi H, Ohta K, Higashikawa K, Takechi M, Takata T, Kamata N. Establishment of mesenchymal cell line derived from human developing odontoma. Oral Dis 18(8):756-762, 2012. (IF:2.9).

  9. Izawa T, Kondo T, Kurosawa M, Oura R, Matsumoto K, Tanaka E, Yamada A, Arakaki R, Kudo Y, Hayashi Y, Ishimaru N. FAS-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice. PLoS ONE 7(12):e48798, 2012. (IF:2.9).

​

2011

  1. Hatano H, Shigeishi H, Kudo Y, Higashikawa K, Tobiume K, Takata T, Kamata N. RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR. Lab Invest 91(3):379-391, 2011. (IF:5.1).

  2. Nguyen PT, Kudo Y*, Yoshida M, Iizuka S, Ogawa I, Takata T. N-cadherin expression is correlated with metastasis of spindle cell carcinoma of head and neck region. J Oral Pathol Med 40(1):77-82, 2011. (IF:2.7).

  3. Iizuka S, Kudo Y*, Yoshida M, Tsunematsu T, Yoshiko Y, Uchida T, Ogawa I, Miyauchi M, Takata T. Ameloblastin regulates osteogenic differentiation by inhibiting Src kinase via cross talk between integrin beta 1 and CD63. Mol Cell Biol 31(4):783-792, 2011. (IF:3.2).

  4. Nguyen PT, Kudo Y*, Yoshida M, Kamata N, Ogawa I, Takata T. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol 26(2):147-156, 2011. (IF:2.5).

  5. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Takata T, Shimamoto A, Ochiya T, Tahara H. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193(2):409-424, 2011. (IF:7.4).

  6. Uchida S, Watanabe N, Kudo Y, Yoshioka K, Matsunaga T, Ishizuka Y, Nakagama H, Poon RYC, Yamashita K. SCFßTrcp mediates stress-activated MAPK-induced Cdc25Bdegradation. J Cell Sci 124(Pt 16):2816-2825, 2011. (IF:3.3).

  7. Deraz EM, Kudo Y*, Yoshida M, Obayashi M, Tsunematsu T, Tani H, Siriwardena SB, Kiekhaee MR, Qi G, Iizuka S, Ogawa I, Campisi G, Lo Muzio L, Abiko Y, Kikuchi A, Takata T. MMP-10/stromelysin-2 promotes invasion of head and neck cancer. PLoS ONE 6(10):e25438, 2011. (IF:2.9).

  8. Kudo Y*, Tsunematsu T, Takata T. Oncogenic role of RUNX3 in head and neck cancer. J Cell Biochem 112(2):387-393, 2011. (IF:3)

  9. 小川郁子，工藤保誠，高田隆．唾液腺腫瘍の病理 -小唾液腺腫瘍を中心に-．日本口腔腫瘍学会誌 23(3):50-58, 2011.

 

2010

  1. Qi G, Kudo Y*, Ando T, Tsunematsu T, Shimizu N, Siriwardena BS, Yoshida M, Keikhaee M, Ogawa I, Takata T. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B. Oral Oncol 46(4):263-270, 2010. (IF:4).

  2. Kudo Y*, Tsunematsu T, Takata T. Deregulation of anaphase promoting complex/cyclosome dependent proteolysis in cancer. J Oral Biosci 52(4):388-401, 2010. (IF:2.6)

  3. 小川郁子，北川雅恵，工藤保誠，宮内睦美，高田隆．小唾液腺に発生する腫瘍と腫瘍類似病変．日本唾液腺学会誌 51:39-48, 2010.

​

2009

  1. Siriwardena BS, Kudo Y*, Ogawa I, Tilakaratne WM, Takata T. Aberrant beta-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma. Oral Oncol 45(2):103-108, 2009. (IF:4).

  2. Tatsuka M, Sato S, Kanda A, Miki T, Kamata N, Kitajima S, Kudo Y, Takata T. Oncogenic role of nuclear accumulated Aurora-A. Mol Carcinog 48(9):810-820, 2009. (IF:3).

  3. Tsunematsu T, Kudo Y*, Iizuka S, Ogawa I, Fujita T, Kurihara H, Abiko Y, Takata T. RUNX3 has an oncogenic role in head and neck cancer. PLoS ONE 4(6):e5892, 2009. (IF:2.9).

​

2008

  1. Tanaka E, Rego EB, Iwabuchi Y, Inubushi T, Koolstra JH, van Eijden TMGJ, Kawai N, Kudo Y, Takata T, Tanne K. Biomechanical response of condylar cartilage-on-bone to dynamic shear. J Biomed Mater Res A 85(1):127-132, 2008. (IF:3.9).

  2. Siriwardena BS, Kudo Y*, Ogawa I, Udagama MN, Tilakaratne WM, Takata T. VEGF-C is associated with lymphatic status and invasion in oral cancer. J Clin Pathol 61(1):103-108, 2008. (IF:2.5).

  3. Sato S, Kitagawa M, Sakamoto K, Iizuka S, Kudo Y, Ogawa I, Miyauchi M, Foster BL, Somerman MJ, Takata T. Enamel matrix derivative exhibits anti-inflammation properties in monocytes. J Periodontol 79(3):535-540, 2008. (IF:4.2).

  4. Hatano H, Kudo Y*, Ogawa I, Tsunematsu T, Kikuchi A, Abiko Y, Takata T. IFN-induced transmembrane protein 1 promotes the invasion at the early stage of head and neck cancer progression. Clin Cancer Res 14(19):6097-6105, 2008. (IF:10.4).

​

2007

  1. Qi G, Ogawa I, Kudo Y, Miyauchi M, Siriwardena BS, Shimamoto F, Tatsuka M, Takata T. Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer. Virchows Arch 450(3):297-302, 2007. (IF:3.4).

  2. Kitagawa M, Ueda H, Iizuka S, Sakamoto K, Oka H, Kudo Y, Ogawa I, Miyauchi M, Tahara H, Takata T. Immortalization and characterization of human dental pulp cells with odontoblastic differentiation. Arch Oral Biol 52(8):727-731, 2007.(IF:2.2).

  3. Keikhaee MR, Kudo Y*, Siriwardena S, Wu L, Ogawa I, Takata T. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma. Virchows Arch 450(5):567-574, 2007. (IF:3.4).

  4. Siriwardena BS, Tilakanatne A, Amaratunga EA, Udagama MN, Ogawa I, Kudo Y, Takata T, Tilakaratne WM. Analysis of histopathological and immunohistochemical differences of oral squamous cell carcinoma in young and old patients in Sri Lanka. J Oral Pathol Med 36(6):357-362, 2007. (IF:2.7).

  5. Kitagawa M, Ogawa I, Shima K, Hashimoto S, Kudo Y, Miyauchi M, Tahara H, Shimono M, Takata T. Immortalization and characterization of pleomorphic adenoma cells by transfection with the hTERT gene. Int J Oncol 31(2):339-344, 2007.(IF:4.9).

  6. Kitajima S, Kudo Y*, Ogawa I, Tatsuka M, Kawai H, Pagano M, Takata T. Constitutive phosphorylation of Aurora-A on Ser51 induces its stabilization and consequent overexpression in cancer. PLoS ONE 2(9):e944, 2007. (IF:2.9).

  7. Kudo Y*, Siriwardena BSMS, Hatano H, Ogawa I, Takata T. Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol 22(10):1167-1174, 2007. (IF:2.5)

 

2006

  1. Kudo Y*, Ogawa I, Kitajima S, Kitagawa M, Kawai H, Gaffney PM, Miyauchi M, Takata T. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66(14):6928-6935, 2006.(IF:12.5).

  2. Kitagawa M, Kitagawa S, Kudo Y, Ogawa I, Miyauchi M, Tahara H, Ide T, Takata T. Characterization of established human cementoblast-like cell lines from human cementum-lining cells in vitro and in vivo. Bone 39(5):1035-1042, 2006. (IF:3.5).

  3. Kudo Y*, Ogawa I, Kitagawa M, Kitajima S, Siriwardena S, Aobara N, Matsuda C, Miyauchi M, Takata T. Establishment and characterization of a spindle cell squamous carcinoma cell line. J Oral Pathol Med 35(8):479-483, 2006. (IF:2.7).

  4. Kitagawa M, Kudo Y, Iizuka S, Ogawa I, Abiko Y, Miyauchi M, Takata T. Effect of F-spondin on cementoblastic differentiation of human periodontal ligament cells. Biochem Biophys Res Commun 349(3):1050-1056, 2006. (IF:2.5).

  5. Siriwardena BS, Kudo Y*, Ogawa I, Kitagawa M, Kitajima S, Hatano H, Tilakaratne WM, Miyauchi M, Takata T. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer 95(10):1396-1403, 2006. (IF:6.4).

  6. Kudo Y*, Keikhaee MR, Kitajima S, Ogawa I, Miyauchi M, Takata T. Degradation of cyclin-dependent kinase inhibitor p27Kip1 in oral cancer. Oral Med Pathol 11(1):19-26, 2006. (IF: -)

​

2005

  1. Kudo Y*, Kitajima S, Ogawa I, Kitagawa M, Miyauchi M, Takata T. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. Mol Cancer Ther 4(3): 471-476, 2005. (IF:5.4).

  2. Kitagawa M, Kitagawa S, Kudo Y, Ogawa I, Miyauchi M, Tahara H, Ide T, Takata T. Establishment of cementoblast cell lines from rat cementum lining cells by transfection with temperature-sensitive simian virus-40 T-antigen gene. Bone 37(2):220-226, 2005. (IF:3.5)

  3. Kudo Y*, Kitajima S, Ogawa I, Miyauchi M, Takata T. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma. Oral Oncol 41(2):105-116, 2005. (IF:4)

  4. 小川郁子，北川雅恵，工藤保誠，宮内睦美，高田隆．唾液腺腫瘍の分子病理．日本唾液腺学会誌46:57-68, 2005.​

 

2004

  1. Miyauchi M, Kitagawa S, Hiraoka M, Saito A, Sato S, Kudo Y, Ogawa I, Takata T. Immunolocalization of CXC chemokine and recruitment of polymorphonuclear leukocytes in the rat molar periodontal tissue after topical application of lipopolysaccharide. Histochem Cell Biol 121(4):291-297, 2004. (IF:2.1).

  2. Sato S, Miyauchi M, Kato M, Kitajima S, Kitagawa S, Hiraoka M, Kudo Y, Ogawa I, Takata T. Upregulated CD44 v9 expression inhibits the invasion of oral squamous cell carcinoma cells. Pathobiology 71(4):171-175, 2004. (IF:3.5).

  3. Kudo Y*, Kitajima S, Ogawa I, Hiraoka M, Salgolzaei S, Keikhaee MR, Sato S, Miyauchi M, Takata T. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous β-catenin. Clin Cancer Res 10(16):5455-5463, 2004. (IF:10.4).

  4. Kudo Y, Guardavaccaro D, Santamaria PG, Nasu R, Latres E, Bronson R, Richardson A, Yamasaki Y, Pagano M. Role of F-box protein βTrcp1 in mammary gland development and tumorigenesis. Mol Cell Biol 24(18):8184-8194, 2004. (IF:3.2).

  5. Kitajima S, Kudo Y*, Ogawa I, Bashir T, Kitagawa M, Miyauchi M, Pagano M, Takata T. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation. Am J Pathol 165(6):2147-2155, 2004.(IF:4.7).

  6. Miyauchi M, Hiraoka M, Oka H, Sato S, Kudo Y, Ogawa I, Noguchi K, Ishikawa I, Takata T. Immuno-localization of COX-1 and COX-2 in the rat molar periodontal tissue after topical application of lipopolysaccharide. Arch Oral Biol 49(9):739-746, 2004. (IF:2.2).

  7. Takata T, Kudo Y, Kitajima S, Ogawa I, Sato S, Miyauchi M. Studies on the Novel Gene Diagnosis and Therapy Targeting p27 and Its Related Factors for Oral Malignancies. J Oral Biosci 46(2):97-106, 2004. (IF:2.6)

​

2003

  1. Sato S, Miyauchi M, Ogawa I, Kudo Y, Kitagawa S, Hiraoka M, Takata T. Inhibition of CD44v9 upregulates the invasion ability of oral squamous cell carcinoma cells. Oral Oncol 39(1):27-30, 2003. (IF:4).

  2. Ogawa I, Sato S, Kudo Y, Miyauchi M, Sugiyama M, Suei Y, Takata T. Solitary fibrous tumor with malignant potential arising in sublingual gland. Pathol Int 53(1):40-45, 2003. (IF:2.5).

  3. Kudo Y*, Kitajima S, Sato S, Ogawa I, Miyauchi M, Takata T. Establishment of an oral squamous cell carcinoma cell line with high invasive and p27 degradation activity from lymph node metastasis. Oral Oncol 39(5):515-520, 2003. (IF:4).

  4. Guardavaccaro D, Kudo Y, Boulaire J, Barchi M, Busino L, Donzelli M, Margottin F, Jackson P, Yamasaki L, Pagano M. Control of meiotic and mitotic progression by the F-box protein β-Trcp1 in vivo. Dev Cell 4(6):799-812, 2003. (IF:10.7).

  5. Lo Muzio L, Pannone G, Leonardi R, Staibano S, Mignogna MD, De Rosa G, Kudo Y, Takata T, Altieri DC. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 82(11):923-928, 2003. (IF:5.7).

  6. 工藤保誠*，北島正二朗，小川郁子，高田隆．SCF複合体によるタンパク質のユビキチン化．広島大学歯学雑誌 35(2):221-224, 2003.

​

2002

  1. Leonardi R, Pannone G, Margo G, Kudo Y, Takata T, Lo Muzio L. Differential expression of heat shock protein 27 in normal oral mucosa, oral epithelial dysplasia and squamous cell carcinoma. Oncol Rep 9(2):261-266, 2002. (IF:3.8).

  2. Kudo Y*, Hiraoka M, Kitagawa S, Miyauchi M, Kakuo S, Zhao M, Ide T, Takata T. Establishment of human cementifying fibroma cell lines by transfection with temperature-sensitive simian virus-40 T-antigen gene and hTERT gene. Bone 30(5):712-717, 2002. (IF:3.5).

  3. Kudo Y*, Kitajima S, Sato S, Ogawa I, Miyauchi M, Takata T. Transfection of p27Kip1 threonine residue 187 mutant type gene, which is not influenced by ubiquitin-mediated degradation, induces cell cycle arrest in oral squamous cell carcinoma cells. Oncology 63(4):398-404, 2002. (IF:2.5). 

  4. Matsuda N, Horikawa M, Watanabe M, Kitagawa S, Kudo Y, Takata T. Possible involvement of extracellular-signal related kinases 1/2 in mitogenic response of periodontal ligament cells to enamel matrix derivatives. Eur J Oral Sci 110(6):439-444, 2002. (IF:1.8).

​

2001

  1. Philipsen HP, Reichart PA, Nikai H, Takata T, Kudo Y. Peripheral ameloblastoma: biological profile based on 160 cases from the literature. Oral Oncol 37(1):17-27, 2001. (IF:4).

  2. Miyauchi M, Sato S, Kitagawa S, Hiraoka M, Kudo Y Ogawa I, Zhao M, Takata T. Cytokine expression in rat molar gingival periodontal tissues after topical application of lipopolysaccharide. Histochem Cell Biol 116(1):57-62, 2001. (IF:2.1).

  3. Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 61(19):7044-7047, 2001.(IF:12.5.).

2000

  1. Fujimoto J, Yasui W, Tahara H, Tahara E, Kudo Y, Yokozaki H, Tahara E. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. Cancer Lett 149(1-2), 125-134, 2000. (IF:9.1)

  2. Kudo Y*, Takata T, Ogawa I, Zhao M, Sato S, Takekoshi T, Miyauchi M, Nikai H. Reduced expression of p27Kip1 correlates with an early stage of cancer invasion in oral squamous cell carcinoma. Cancer Lett 151(2):217-222, 2000. (IF:9.1). 

  3. Kudo Y*, Takata T, Ogawa I, Sato S, Kaneda T, Takekoshi T, Zhao M, Miyauchi M, Nikai H. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells. Clin Cancer Res 6(3):916-923, 2000.(IF:10.4). 

  4. Takata T, Miyauchi M, Ogawa I, Kudo Y, Takekoshi T, Zhao M, Sato S, Nikai H. Immunoexpression of transforming growth factor beta in desmoplastic ameloblastoma. Virchows Arch 436(4):319-323, 2000. (IF:3.4)

  5. Takata T, Zhao M, Uchida T, Kudo Y, Sato S, Nikai H. Immunohistochemical demonstration of an enamel sheath protein, sheathlin, in odontogenic tumors. Virchows Arch 436(4):324-329, 2000. (IF:3.4)

  6. Sato S, Miyauchi M, Takekoshi T, Zhao M, Kudo Y, Ogawa I, Kitagawa S, Fujita M, Takata T. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol 36(6):545-549, 2000. (IF:4)

  7. 高田隆，工藤保誠，趙明，小川郁子，宮内睦美，佐藤淳，二階宏昌．腺様嚢胞癌におけるp27Kip1タンパク発現低下の臨床的意義とその機序. 日本唾液腺学会 41:64-66, 2000.

 

1999

  1. Kudo Y*, Takata T, Ogawa I, Sato S, Nikai H. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Oncol Rep 6(3):539-545, 1999. (IF:3.8) 

  2. Takata T, Kudo Y, Zhao M, Ogawa I, Miyauchi M, Sato S, Cheng J, Nikai H. Reduced expression of p27Kip1 protein in relation to salivary adenoid cystic carcinoma metastasis. Cancer 86(6):928-935, 1999. (IF:6.1)

  3. Takata T, Miyauchi M, Ito H, Ogawa I, Kudo Y, Zhao M, Sato S, Takekoshi T, Nikai H, Tanimoto K. Clinical and histopathological analyses of desmoplastic ameloblastoma. Pathol Res Prac 195(10):669-675, 1999. (IF:2.9)

  4. Zhao M, Takata T, Kudo Y, Sato S, Ogawa I, Wakida K, Uchida T, Nikai H. Biosynthesis of glycosaminoglycans and aggrecan by tumor cells in salivary pleomorphic adenoma: ultrastructural evidence. J Oral Pathol Med 28(10):442-450, 1999. (IF:2.7)

  5. Takata T, Miyauchi M, Ogawa I, Zhao M, Kudo Y, Sato S, Takekoshi T, Nikai H, Tanimoto K. So-called "hybrid" lesion of desmoplastic and conventional ameloblastoma: report of a case and review of the literature. Pathol Int 49(11):1014-1018, 1999. (IF:2.5)

  6. 工藤保誠*，高田隆，宮内睦美，二階宏昌，小川郁子. 細胞周期と口腔癌．広島大学歯学雑誌 31(2):183-185, 1999.

​

1998

  1. Miyauchi M, Takata T, Ito H, Ogawa I, Kudo Y, Takekoshi T, Nikai H. Distribution of macrophage lineage cells in rat gingival tissue after topical application of lipopolysaccharide: an immunohistochemical study using monoclonal antibodies: OX6, ED1 and ED2. J Periodontal Res 33(6):345-351, 1998. (IF:2.9)

  2. Kudo Y*, Takata T, Yasui W, Ogawa I, Miyauchi M, Takekoshi T, Tahara E, Nikai H. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma. Cancer 83(12):2447-2455, 1998. (IF:6.1) 

  3. Yasui W, Kudo Y, Naka K, Fujimoto J, Ue T, Yokozaki H, Tahara E. Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: Relation to the proliferation and progression. Int J Oncol 12(6):1253-1258, 1998. (IF:4.5)

​

1997

  1. Ogawa I, Takata T, Miyauchi M, Ito H, Zhao M, Kudo Y, Nikai H. nm23-H1 expression in salivary adenoid cystic carcinoma in relation to metastasis and survival. Oncol Rep 4(4):707-711, 1997. (IF:3.8)

  2. Yasui W, Kudo Y, Semba S, Yokozaki H, Tahara E. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res 88(7):625-629, 1997. (IF: 4.5)

  3. Kudo Y, Yasui W, Ue T, Yamamoto S, Yokozaki H, Nikai H, Tahara E. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinoma. Jpn J Cancer Res** 88(10):947-952, 1997. (IF:4.5)（**2003年よりCancer Scienceに雑誌名変更）

  4. Yasui W, Akama Y, Yokozaki H, Semba S, Kudo Y, Shimamoto F, Tahara E. Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. Pathol Int 47(7):470-477, 1997. (IF:2.5)

​症例報告など

  1. 田邊舞，三井康裕，倉橋清衛，牛尾綾，北村晋志，岡本耕一，佐藤康史，六車直樹，工藤保誠，高山哲治．予後不良の転帰をたどったparathyroid hormon-related protein (PTHrP)及びgranulocyte-colony stimulating factor (G-CSF)産生胃体部癌の１剖検例．日本内科学会雑誌110巻2号：289-294.

  2. Hichijo N, Kudo Y, Tanaka E. Orthodontic treatment of open-bite involved in diffuse hypercementosis: A case report. J Am Dent Assoc 152(2):166-175, 2021. (IF:3.454)

  3. Tomita R, Kitamura N, Yoshizawa Y, Sasabe E, Kudo Y, Yamamoto T. A case of large varix including partially organizing thrombosis on the oral floor. J Oral Maxillofac Surg Med Pathol 32(4):313-315, 2020. (IF:-)

  4. Sento S, Kudo Y, Hibiya K, Ishimaru N, Sasabe E, Kitamura N, Yamamoto T. Hyalinizing clear cell carcinoma of the anterior lingual salivary gland: A case report and review of the literature. J Oral Maxillofac Surg Med Pathol 32(4):267-274, 2020. (IF:-)

  5. 波多野寛子，重石秀生，工藤保誠，東川晃一郎，飛梅圭，高田隆，鎌田伸之．骨形成線維腫の病態解明への基礎研究. Tiss Cult Res Commun 30:135-43, 2011.

  6. Deraz EM, Ogawa I, Miyauchi M, Kudo Y, Nakamoto T, Tani R, Takata T. Central giant cell granuloma of the mandible: presentation of a rare case with prominent osteoblastic differentiation mimicking osteosarcoma. Oral Med Pathol 14:109-112, 2010. (IF: -)

  7. 小川郁子，宮内睦美，工藤保誠，高田隆．歯原性腫瘍の病理診断．病理と臨床 23:1186-1193, 2005.

  8. 小川郁子，工藤保誠，高田隆．唾液腺腫瘍の遺伝子異常．病理と臨床 20:59-63, 2002.

  9. 高田隆, 宮内睦美, 小川郁子, 工藤保誠．歯原性腫瘍の組織発生と病態. 病理と臨床 19:275-280, 2001.

  10. 小川郁子，工藤保誠，高田隆．唾液腺腫瘍における遺伝子異常．病理と臨床 20:59-63, 2001.

  11. 小川郁子, 佐藤　淳, 工藤保誠, 宮内睦美, 高田　隆, 松浦博夫．腺様嚢胞癌様の組織像を広範に伴った多形性腺腫の１例. 日本唾液腺学会誌 42:21-4, 2001

  12. Takekoshi T, Ogawa I, Takata T, Miyauchi M, Zhao M, Kudo Y, Sato S, Nikai H. “Malignant pleomorphic adenoma” in the palate. Oral Med Pathol 5: 49-52, 2000. (IF: -)

  13. 小川郁子，高田隆，宮内睦美，趙明，工藤保誠，佐藤淳，二階宏昌，杉山勝，末井良和．生検診断が困難であった舌下腺部 solitary fibrous tumor の1例. 日本唾液腺学会誌 41:23-24, 2000.

  14. Sato S, Takata T, Takekoshi T, Kudo Y, Zhao M, Miyauchi M, Ogawa I, Nakajima H, Nikai H. Squamous cell carcinoma of the tongue with glandular differentiation. Oral Med Pathol 4:101, 1999. (IF: -)

  15. 小川郁子，工藤保誠，宮内睦美，高田隆，吉賀浩二．口腔癌の放射線治療後に発生した悪性線維性組織球腫．病院病理16:19, 1998.

  16. 工藤保誠，高田隆，小川郁子，宮内睦美，二階宏昌．口腔扁平上皮癌におけるプロテアソームによるp27Kip1タンパクの分解. 口腔組織培養研究会誌7：79-80, 1998.

  17. Sato S, Ogawa I, Takata T, Takekoshi T, Kudo Y, Zhao M, Miyauchi M, Ito H, Hachisuka E, Nikai H. Polymorphous low-grade adenocarcinoma of the upper lip. Oral Med Pathol 3:115,1998. (IF: -)

  18. 工藤保誠，安井弥，堀部よし恵，横崎宏，二階宏昌，田原榮一．耳下腺に発生した腺房細胞癌の１例．広島医学 50(1):47-50, 1997.

  19. 工藤保誠，安井弥，横崎宏，二階宏昌，田原榮一．胃腺腫および胃癌における細胞周期調節因子CDC25Bの免疫組織化学的検討．腫瘍マーカー研究会誌13: 175-177, 1997.

  20. Kudo Y, Yasui W, Akama H, Kuniyasu H, Yokozaki H, Nikai H, Tahara E. Expression of a cell cycle regulator CKshs1, in gastrointestinal carcinomas. Recent Advances in Gastroenterological Carcinogenesis I, pp.755-759, 1996. (IF: -)

​

​著　書

  1. Periostin. Kudo Y. Encyclopedia of Cancer, 4th edition, Vol. 1 (Schwab M (Ed.), Springer-Verlag), 2017.

  2. The non-canonical role of Aurora-A in DNA replication. Tsunematsu T, Arakaki R, Yamada A, Ishimaru N, Kudo Y. Aurora Kinases: Classical Mitotic Roles, Non-canonical Functions and Translational Views (de Castro IP, Carmena M, Prigent C, Glover DM (Ed.), Frontiers Media), pp.116-122, 2017.

  3. High levels of saturated fatty acids may exacerbate the pathogenesis of primary Sjögrens syndrome. Shikama Y, Ishimaru N, Kudo Y, Arakaki R, Bandou Y, Aki N, Funaki M. Interface Oral Health Science (Sasaki K, Suzuki O, Takahashi N (Ed.), Springer), pp. 217-224, 2014.

  4. 唾液腺腫瘍の病理 病理診断を中心に. 小川郁子, 北川雅恵, 工藤保誠, 宮内睦美, 高田隆. 口腔外科ハンドマニュアル'11 (日本口腔外科学会編, クインテッセンス出版), pp.144-150, 2011.

  5. 妊婦に見られた歯肉腫脹．山田京子, 林正規, 工藤保誠，高田隆. 口腔病変クローズアップ (高田隆，小川郁子監著, デンタルダイヤモンド社)，pp.22-24, 2010.

  6. 口腔清掃不良と関係した歯肉腫瘤．高木紀子, 高橋正光, 工藤保誠，高田隆. 口腔病変クローズアップ (高田隆，小川郁子監著, デンタルダイヤモンド社)，pp.25-27, 2010.

  7. 降圧剤服用患者に見られた歯肉腫脹. 山田京子, 林正規, 工藤保誠，高田隆. 口腔病変クローズアップ (高田隆，小川郁子監著, デンタルダイヤモンド社), pp.50-52, 2010.

  8. 難治性の潰瘍を伴う粘膜腫瘤．安藤あずさ，佐々木晶浩，工藤保誠，高田隆. 口腔病変クローズアップ (高田隆，小川郁子監著, デンタルダイヤモンド社), pp.56-59, 2010.

  9. 口底部に生じた半透明の膨隆．藤掛文恵，湯淺裕子，翠川鎭生，翠川伊都子，工藤保誠，高田隆. 口腔病変クローズアップ (高田隆，小川郁子監著, デンタルダイヤモンド社), pp.76-78, 2010.

  10. 要介護者に見られた口腔粘膜の白色病変．一之瀬くにこ，馬見塚賢一郎，工藤保誠，高田隆. 口腔病変クローズアップ (高田隆，小川郁子監著, デンタルダイヤモンド社), pp.86-88, 2010.

  11. 無痛性の口蓋部隆起性病変．渡邉照代，高橋正光，工藤保誠，高田隆. 高田隆，小川郁子監著，口腔病変クローズアップ (高田隆，小川郁子監著, デンタルダイヤモンド社), pp.89-91, 2010.

  12. 黄白色顆粒状の頬粘膜病変．高木紀子，高橋正光，工藤保誠，高田隆. 高田隆，小川郁子監著，口腔病変クローズアップ(高田隆，小川郁子監著, デンタルダイヤモンド社), pp.98-100，2010.

  13. 埋伏歯を入れたX線透過性病変．菊田美香，甲原玄秋，工藤保誠，高田隆. 高田隆，小川郁子監著，口腔病変クローズアップ(高田隆，小川郁子監著, デンタルダイヤモンド社), pp.113-116, 2010.

  14. 佐藤亜樹，梅本丈二，工藤保誠，高田隆.骨膨隆を伴う多房性X線透過性病変．高田隆，小川郁子監著，口腔病変クローズアップ(高田隆，小川郁子監著, デンタルダイヤモンド社), pp.117-120, 2010.

  15. 各論2 歯・顎骨. 小川郁子, 工藤保誠, 宮内睦美, 高田隆. 病理と臨床臨時増刊号Vol.26，外科病理マニュアル (分光堂)，pp.139-143，2008．

  16. 免疫異常. 高田隆, 工藤保誠. スタンダ−ド病理学 (下野正基編, 学建書院), pp.160-189, 2005.

Case Report

​

＆

​

Book

bottom of page